Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.38 USD -1.3% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one AUPH stock under the Base Case scenario is 15 USD. Compared to the current market price of 8.38 USD, Aurinia Pharmaceuticals Inc is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AUPH Relative Value
Base Case
15 USD
Undervaluation 44%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
68
Median 3Y
8.7
Median 5Y
23.7
Industry
8.1
Forward
5
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-13.2
Industry
23
Forward
704
vs History
vs Industry
Median 3Y
-24.9
Median 5Y
-21.8
Industry
23.4
vs History
vs Industry
Median 3Y
-22.4
Median 5Y
-20.3
Industry
27.3
vs History
69
vs Industry
41
Median 3Y
3.3
Median 5Y
3.9
Industry
2.6
vs History
80
vs Industry
64
Median 3Y
6.5
Median 5Y
17.4
Industry
8.1
Forward
3.9
vs History
52
vs Industry
63
Median 3Y
6.9
Median 5Y
5.2
Industry
9.6
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-11.8
Industry
4.3
Forward
23.4
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
-11.2
Industry
3.8
Forward
186.4
vs History
vs Industry
Median 3Y
-19.2
Median 5Y
-17.6
Industry
6
vs History
vs Industry
Median 3Y
-19
Median 5Y
-17.4
Industry
3.8
vs History
76
vs Industry
42
Median 3Y
6.2
Median 5Y
17.4
Industry
4.8

Multiples Across Competitors

AUPH Competitors Multiples
Aurinia Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
1.2B USD 5.8 -23.8 -28.4 -17.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 380 957.8 -177 666.1 -215 743.3 -213 281.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 14.9 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 17.7 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
117.6B USD 4.2 933 10.4 10.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 884.6 -480.9 -523.7 -509.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.1 34.3 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 17.9 19.9
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.7 -59.8 -54
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.2 -127.9 -102.8 -74.9
P/E Multiple
Earnings Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average P/E: 216.8
Negative Multiple: -23.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
933
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average EV/EBITDA: 18.1
Negative Multiple: -28.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 743.3 N/A
US
Abbvie Inc
NYSE:ABBV
14.9
28%
US
Amgen Inc
NASDAQ:AMGN
17.7
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.7 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.8 N/A
EV/EBIT Multiple
EBIT Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average EV/EBIT: 23.5
Negative Multiple: -17.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 281.4 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -509.7 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.9 N/A

See Also

Discover More
Back to Top